DalsnaFinance › IPOs › Allogene Therapeutics Inc › IPO
Allogene Therapeutics, Inc. completed its initial public offering on NASDAQ on October 11, 2018, pricing at $18.00 a share.
| Ticker | ALLO |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | October 11, 2018 |
| Offering price | $18.00 |
| Shares offered | 18,000,000 |
| Total raised | $324M |
Allogene Therapeutics, Inc. sold 18,000,000 shares at $18.00 each on NASDAQ. Multiplied out, that is $324 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $324 million total recorded for the deal.
Allogene Therapeutics, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Allogene Therapeutics, Inc.. This page is general information, not investment advice.